SCOTT ARMS MEDICAL CENTRE
WHITECREST, GREAT BARR, BIRMINGHAM
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 26 | 42 | 61.9% | |
| HF 4 | 2011 | 27 | 44 | 61.4% | |
| HF 4 | 2012 | 27 | 45 | 60.0% | |
| HF 4 | 2013 | 26 | 40 | 65.0% | |
| HF004 | 2014 | 22 | 30 | 73.3% | |
| HF004 | 2015 | 21 | 28 | 75.0% | |
| HF004 | 2016 | 18 | 25 | 72.0% | |
| HF004 | 2017 | 22 | 26 | 84.6% | |
| HF004 | 2018 | 23 | 27 | 85.2% | |
| HF004 | 2019 | 40 | 44 | 90.9% | |
| HF004 | 2020 | 37 | 40 | 92.5% | |
| HF006 | 2021 | 60 | 71 | 84.5% | |
| HF006 | 2022 | 58 | 65 | 89.2% | |
| HF006 | 2023 | 57 | 63 | 90.5% |
